Looking back over my notes of Rohan’s presentation, I think the PKD trial in healthy volunteers is scheduled for Q2-3 next year and in PKD patients in Q4. We also know that PYC can’t foot the bill for full trials. Does that mean that they will allow a partner to lease the product after they have completed the healthy volunteer trial?
If so, that means we should have a license deal done inside 12 months from now. With the re-rate of the SP that will go along with it.
Ann: 2024 AGM Chairman's Address and CEO Presentation, page-13
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.26 |
Change
0.020(1.61%) |
Mkt cap ! $734.9M | |||
| Open | High | Low | Value | Volume |
| $1.25 | $1.28 | $1.25 | $53.59K | 42.67K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 3209 | $1.25 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.26 | 913 | 1 |
View Market Depth
| Last trade - 11.42am 25/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |